REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 126 filers reported holding REVOLUTION MEDICINES INC in Q1 2022. The put-call ratio across all filers is 0.16 and the average weighting 1.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $1,395,842 | +184.3% | 52,181 | +107.0% | 0.04% | +68.2% |
Q2 2022 | $491,000 | +106.3% | 25,212 | +170.3% | 0.02% | +100.0% |
Q1 2022 | $238,000 | -51.2% | 9,327 | -51.9% | 0.01% | -63.3% |
Q4 2021 | $488,000 | +52.5% | 19,400 | +92.3% | 0.03% | +11.1% |
Q2 2021 | $320,000 | -17.3% | 10,089 | +19.6% | 0.03% | -25.0% |
Q1 2021 | $387,000 | – | 8,439 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP III, LLC | 5,524,031 | $151,966,000 | 28.85% |
Ponoi II Management, LLC | 685,011 | $18,845,000 | 27.92% |
Ponoi Management, LLC | 685,011 | $18,845,000 | 16.73% |
Column Group LLC | 3,347,245 | $92,083,000 | 10.48% |
TRV GP IV, LLC | 1,419,900 | $39,061,000 | 8.86% |
Cormorant Asset Management, LP | 3,144,700 | $86,511,000 | 3.52% |
Boxer Capital, LLC | 3,484,264 | $95,852,000 | 3.35% |
BVF INC/IL | 2,485,049 | $68,364,000 | 2.67% |
Casdin Capital, LLC | 2,800,000 | $77,028,000 | 1.92% |
COMMODORE CAPITAL LP | 226,228 | $6,224,000 | 1.64% |